REQUEST A DEMO
Total
USD $0.00
Search more companies

Hematogenix Sdn. Bhd. (Malaysia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Medical Laboratories | Specialty (except Psychiatric and Substance Abuse) Hospitals
Full name: Hematogenix Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Hematogenix Sdn. Bhd. is based in Malaysia. The head office is in Cyberjaya. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on November 17, 2017. In its most recent financial highlights, the company reported a net sales revenue increase of 288.35% in 2022. Over the same period, its total assets grew by 6.54%.

Headquarters
A4-1 Block A, Jalan Radius 1/1B, Jalan Teknokrat 2/1 Radius Business Park,Cyber 4
Cyberjaya; Selangor; Postal Code: 63000

Contact Details: Purchase the Hematogenix Sdn. Bhd. report to view the information.

Website: http://hematogenix.com/

Basic Information
Outstanding Shares:
Purchase the Hematogenix Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Hematogenix Sdn. Bhd. report to view the information.
Incorporation Date:
November 17, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hematogenix Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
288.35%
Total operating revenue
288.35%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
6.54%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
295.23%
Quick Ratio
0.17%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?